Early Life
Franz von Baumbach is the heir to the Boehringer Ingelheim fortune, a German pharmaceutical company. Little is publicly known about his early life, as the family maintains a low profile, prioritizing privacy.
Rise to Success
Franz's wealth comes from his stake in Boehringer Ingelheim. The company was founded in 1885 and has grown into a global pharmaceutical giant with a presence in 130 markets. His family's involvement has spanned generations, with key leadership roles within the company, indicating a strong family legacy.
Key Business Strategies
The Boehringer Ingelheim strategy has been to remain a privately-held company, allowing for a focus on long-term goals. They are known for their research and ethical business practices. The company's development of Spiriva, a treatment for chronic obstructive pulmonary disease (COPD), established it as a leader in respiratory healthcare.
Philanthropy
The Boehringer and Von Baumbach families are committed to philanthropy. The Boehringer Ingelheim Foundation funds scientific research and education, with other family initiatives focused on public health, environmental sustainability, and social welfare.